PTG’s Q3/2018 performance which would significantly worsen through her securities trading accounts during 4 – 5 October 2018 prior to the disclosure of such inside information to the public on 8
PTG’s Q3/2018 performance which would significantly worsen through his securities trading accounts on 4 October 2018 prior to the disclosure of such inside information to the public on 8 November 2018
PTG’s Q3/2018 performance which would significantly worsen through his securities trading accounts during 3 September 2018 to 2 November 2018 prior to the disclosure of such inside information to the
significantly worsen. Subsequently, during 3 September 2018 to 5 November 2018 prior to PTG’s disclosure of such inside information to the public on 8 November 2018, Mr. Tharathon sold PTG stocks by using such
for sale newly issued securities shares for a private placement without obtaining a prior approval from the SEC on 11 October, 2017. SEC Act S.300 in conjunction with 33 Settlement Committee Meeting
for a private placement without obtaining a prior approval from the SEC on 7 March, 2018. SEC Act S.300 in conjunction with 33 Settlement Committee Meeting No. 4/2019 Settlement Committee Order No
sale newly issued securities in the category of of debt securities to high-net-worth investors on a program basis without providing its securities for credit rating prior to the offer for sale of the
2018 compared to the prior year was increasing in net profit amounting to Baht 30.48 million or 208.01% because of the following main reasons. 1. Revenue from hospital operations increased by Bath 45.32
million, we wish to clarify the changes in our operating results as follows: ‐ Sales Revenue was increased by Baht 18.30 million or 8.71% compared the same period of prior year. Export Sales Revenue was
Public Company Limited ( “ the Company”) compared with the same quarter of the prior period are as follows: (Unit: Million Baht) Quarter 1 2021 2020 QoQ (%) Total Revenues 1,387.65 745.78 86.07% Gross